Metformin adherence and the risk of cardiovascular disease: a population-based cohort study.

Shun-Fan YuChien-Tai HongWan-Ting ChenLung ChanLi-Nien Chien

Published in: Therapeutic advances in chronic disease (2023)

This study revealed that metformin adherence in patients with T2DM who required a first-line treatment may reduce the risk of subsequent CVD. Despite the availability of numerous novel antiglycemic agents, metformin adherence by patients who require a combination of antiglycemic agents provides an additional benefit of CVD protection.

Keyphrases

cardiovascular disease
glycemic control
type diabetes
single cell
metabolic syndrome
adipose tissue
insulin resistance